Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA Regulatory, Scientific Affairs To Be Headed By P&G’s Bierer

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble exec Douglas Bierer, PhD, will succeed 18-year Consumer Healthcare Products Association veteran William Soller, PhD, in leading the group's regulatory and scientific affairs department effective May 5
Advertisement

Related Content

CHPA To Lobby Against FDA-Initiated Rx-To-OTC Switches
CHPA To Lobby Against FDA-Initiated Rx-To-OTC Switches
OTC Drugs As Tax Deductible Expenses Advocated By CHPA
CHPA’s New President Suydam Brings Extensive FDA Experience To Post

Topics

Advertisement
UsernamePublicRestriction

Register

PS095336

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel